New Review Raises Concerns About mRNA Vaccines and Cancer

Nicholas Halsher discussed findings from a recent thorough review authored by Mathilde Debaud, which examined over 100 studies on the possible connection between mRNA vaccines and cancer rates. The review outlines several ways these vaccines could potentially influence cancer development.

Title: “Comprehensive Literature Review by Mathilde Debaud.” Covid-19 mRNA vaccines can induce cancer in 17 different ways, according to over 100 studies. The review highlights 17 distinct biological mechanisms through which these vaccines might initiate or exacerbate malignant processes.

The review suggests several mechanisms involved, such as:

• Genome instability – The potential for mRNA to integrate into host DNA, leading to mutations.
• Immune Escape – Spike proteins may inhibit tumor suppressor genes, enabling cancer cells to evade immune detection.
• Disruption of DNA repair – Spike proteins could interfere with essential enzymes necessary for DNA repair.
• Chronic Inflammation – Components of the vaccine may induce sustained inflammation, a known cancer driver.
• Immune System Dysregulation – Certain reactions could promote immune evasion and reduce cancer surveillance.
• RNA Disruption – Alterations in microRNA networks might destabilize cell growth regulation.
• Activation of oncogenic pathways – Spike proteins could encourage tumor growth through specific signaling pathways.
• Reactivation of dormant cancer – Post-vaccination inflammation might trigger recurrence in previously remitted cancer patients.
• Multiple doses – Repeated vaccinations may weaken the immune system and encourage tumor resistance.
• Increased treatment resistance – Exposure to spike proteins could help cancer cells survive chemotherapy.

Ivermectin: Possible Cancer Treatment?

There’s a significant focus on cancer treatment avenues, especially given the financial interests of major pharmaceutical companies. However, some healthcare professionals, like Dr. Peter McCullough, are exploring alternative therapies, including Ivermectin, for potential cancer applications.

Initial literature reviews suggest some promise regarding Ivermectin. According to findings from the McCullough Foundation:

Research titled “Review of Ivermectin Use in Cancer Patients: Is it time to reuse ivermectin in cancer treatment?” just published indicates that Ivermectin might be a safe and effective candidate for cancer therapy, given its various anticancer properties and supportive anecdotal evidence.

Mebendazole, another antiparasitic agent like Ivermectin, has a long history of use in treating infections. It’s noteworthy that over 60 million Americans are believed to carry parasites.

Trusted Medicines from Reliable Sources

Healthcare professionals involved in Wellness Company advocate for accurate medical information, especially during health crises like Covid-19. They prioritize patient well-being despite facing censorship challenges.

Now, wellness providers can prescribe a combination of Ivermectin and Mebendazole for extended treatment periods, potentially addressing health issues more effectively.

Ivermectin is scientifically validated, having won a Nobel Prize for its effectiveness against parasitic infections. Similarly, Mebendazole, approved for human use, offers reliable treatment for intestinal parasites.

In conclusion, potential patients can take a simple questionnaire to access these treatments, emphasizing the importance of reliable healthcare options.

What People Are Saying

“I appreciate having access to Ivermectin and Mebendazole, knowing they are made with care in our country. It gives me peace of mind.” – Jennifer W.

“Thank you for the hope and healing provided through this platform!” – Helen